TG THERAPEUTICS INC. - COMMON STOCK

28,77

08-января-25 16:45:00

15 мин. задержка

Акции

+0,77

+2,75%

Сегодняшний диапазон

27,55 - 28,88

ISIN

N/A

Источник

NASDAQ

TG Therapeutics Provides Business Update and Reports Fourth Quarter and Year-End 2020 Financial Results

02 мар 2021 07:00:01 Источник Nasdaq GlobeNewswire
TG Therapeutics to Host Conference Call on Fourth Quarter and Year-End 2020 Financial Results and Business Update

26 фев 2021 07:30:00 Источник Nasdaq GlobeNewswire
TG Therapeutics Announces Publication of Final Results from the Phase 3 GENUINE Trial Evaluating Ublituximab Plus Ibrutinib in Patients with Relapsed/Refractory High-Risk Chronic Lymphocytic Leukemia in The Lancet Haematology

23 фев 2021 07:30:00 Источник Nasdaq GlobeNewswire
TG Therapeutics Announces FDA Accelerated Approval of UKONIQ™ (umbralisib)

05 фев 2021 13:54:45 Источник Nasdaq GlobeNewswire
TG Therapeutics to Participate in the B. Riley Securities Oncology Investor Conference

15 янв 2021 07:00:00 Источник Nasdaq GlobeNewswire
TG Therapeutics to Present at the 39th Annual J.P. Morgan Healthcare Conference

08 янв 2021 07:00:00 Источник Nasdaq GlobeNewswire

<<
<
4
5
6
7
8
>

Принимаю NetDania's website uses cookies. By continuing browsing our website, you agree to our Правила в отношении Cookies, Политика конфиденциальности and Правила и условия.